vs
STANDARD BIOTOOLS INC.(LAB)与Open Lending Corp(LPRO)财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Open Lending Corp的1.0倍($19.6M vs $19.3M),Open Lending Corp同比增速更快(134.0% vs -11.5%),Open Lending Corp自由现金流更多($-3.3M vs $-23.1M),过去两年STANDARD BIOTOOLS INC.的营收复合增速更高(-12.2% vs -20.7%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
开放图书馆是互联网档案馆旗下的非盈利在线项目,旨在实现「每一本出版过的书都拥有专属网页」的目标,由亚伦·斯沃茨等多位开发者共同创立,项目获得了加州州立图书馆和卡勒-奥斯汀基金会的部分资助,为用户提供多种格式的公开领域书籍数字化副本在线阅览服务。
LAB vs LPRO — 直观对比
营收规模更大
LAB
是对方的1.0倍
$19.3M
营收增速更快
LPRO
高出145.5%
-11.5%
自由现金流更多
LPRO
多$19.8M
$-23.1M
两年增速更快
LAB
近两年复合增速
-20.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $19.3M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | 76.0% |
| 营业利润率 | -168.5% | 3.9% |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | 134.0% |
| 净利润同比 | -28.8% | — |
| 每股收益(稀释后) | $-0.09 | $-0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAB
LPRO
| Q4 25 | — | $19.3M | ||
| Q3 25 | $19.6M | $24.2M | ||
| Q2 25 | $21.8M | $25.3M | ||
| Q1 25 | $40.8M | $24.4M | ||
| Q4 24 | — | $-56.9M | ||
| Q3 24 | $22.1M | $23.5M | ||
| Q2 24 | $22.5M | $26.7M | ||
| Q1 24 | $45.5M | $30.7M |
净利润
LAB
LPRO
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $-7.6M | ||
| Q2 25 | $-33.5M | $1.0M | ||
| Q1 25 | $-26.0M | $617.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $1.4M | ||
| Q2 24 | $-45.7M | $2.9M | ||
| Q1 24 | $-32.2M | $5.1M |
毛利率
LAB
LPRO
| Q4 25 | — | 76.0% | ||
| Q3 25 | 48.5% | 78.0% | ||
| Q2 25 | 48.8% | 78.2% | ||
| Q1 25 | 48.4% | 75.1% | ||
| Q4 24 | — | 111.0% | ||
| Q3 24 | 54.9% | 73.9% | ||
| Q2 24 | 46.1% | 78.6% | ||
| Q1 24 | 53.1% | 81.3% |
营业利润率
LAB
LPRO
| Q4 25 | — | 3.9% | ||
| Q3 25 | -168.5% | -31.9% | ||
| Q2 25 | -118.1% | 4.6% | ||
| Q1 25 | -80.8% | 3.1% | ||
| Q4 24 | — | 138.0% | ||
| Q3 24 | -120.9% | 7.9% | ||
| Q2 24 | -134.5% | 14.9% | ||
| Q1 24 | -132.2% | 23.8% |
净利率
LAB
LPRO
| Q4 25 | — | — | ||
| Q3 25 | -177.4% | -31.3% | ||
| Q2 25 | -153.7% | 4.1% | ||
| Q1 25 | -63.8% | 2.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | 6.1% | ||
| Q2 24 | -203.3% | 10.9% | ||
| Q1 24 | -70.6% | 16.5% |
每股收益(稀释后)
LAB
LPRO
| Q4 25 | — | $-0.00 | ||
| Q3 25 | $-0.09 | $-0.06 | ||
| Q2 25 | $-0.09 | $0.01 | ||
| Q1 25 | $-0.07 | $0.01 | ||
| Q4 24 | — | $-1.20 | ||
| Q3 24 | $-0.07 | $0.01 | ||
| Q2 24 | $-0.12 | $0.02 | ||
| Q1 24 | $-0.27 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $176.6M |
| 总债务越低越好 | — | $84.8M |
| 股东权益账面价值 | $399.7M | $75.0M |
| 总资产 | $539.6M | $236.7M |
| 负债/权益比越低杠杆越低 | — | 1.13× |
8季度趋势,按日历期对齐
现金及短期投资
LAB
LPRO
| Q4 25 | — | $176.6M | ||
| Q3 25 | $129.4M | $222.1M | ||
| Q2 25 | $158.6M | $230.7M | ||
| Q1 25 | $150.9M | $236.2M | ||
| Q4 24 | — | $243.2M | ||
| Q3 24 | $210.6M | $250.2M | ||
| Q2 24 | $269.8M | $248.0M | ||
| Q1 24 | $287.1M | $247.0M |
总债务
LAB
LPRO
| Q4 25 | — | $84.8M | ||
| Q3 25 | — | $134.4M | ||
| Q2 25 | — | $136.1M | ||
| Q1 25 | — | $137.9M | ||
| Q4 24 | — | $139.7M | ||
| Q3 24 | $55.2M | $141.5M | ||
| Q2 24 | $55.1M | $143.3M | ||
| Q1 24 | $55.0M | $143.2M |
股东权益
LAB
LPRO
| Q4 25 | — | $75.0M | ||
| Q3 25 | $399.7M | $72.8M | ||
| Q2 25 | $424.5M | $78.9M | ||
| Q1 25 | $454.6M | $79.8M | ||
| Q4 24 | — | $78.1M | ||
| Q3 24 | $489.3M | $220.5M | ||
| Q2 24 | $510.3M | $216.8M | ||
| Q1 24 | $577.3M | $211.5M |
总资产
LAB
LPRO
| Q4 25 | — | $236.7M | ||
| Q3 25 | $539.6M | $287.7M | ||
| Q2 25 | $557.0M | $296.7M | ||
| Q1 25 | $579.6M | $304.2M | ||
| Q4 24 | — | $296.4M | ||
| Q3 24 | $681.5M | $395.7M | ||
| Q2 24 | $708.7M | $382.8M | ||
| Q1 24 | $777.7M | $380.6M |
负债/权益比
LAB
LPRO
| Q4 25 | — | 1.13× | ||
| Q3 25 | — | 1.84× | ||
| Q2 25 | — | 1.72× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | 0.11× | 0.64× | ||
| Q2 24 | 0.11× | 0.66× | ||
| Q1 24 | 0.10× | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-3.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-3.3M |
| 自由现金流率自由现金流/营收 | -118.1% | -16.8% |
| 资本支出强度资本支出/营收 | 4.5% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势,按日历期对齐
经营现金流
LAB
LPRO
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-22.2M | $-5.7M | ||
| Q2 25 | $-20.7M | $848.0K | ||
| Q1 25 | $-30.3M | $-3.8M | ||
| Q4 24 | — | $17.6M | ||
| Q3 24 | $-27.9M | $11.4M | ||
| Q2 24 | $-39.0M | $-1.4M | ||
| Q1 24 | $-62.5M | $11.0M |
自由现金流
LAB
LPRO
| Q4 25 | — | $-3.3M | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | $837.0K | ||
| Q1 25 | $-35.3M | $-3.9M | ||
| Q4 24 | — | $17.4M | ||
| Q3 24 | $-30.1M | $11.3M | ||
| Q2 24 | $-41.0M | $-1.5M | ||
| Q1 24 | $-63.3M | — |
自由现金流率
LAB
LPRO
| Q4 25 | — | -16.8% | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | 3.3% | ||
| Q1 25 | -86.6% | -15.9% | ||
| Q4 24 | — | -30.6% | ||
| Q3 24 | -136.4% | 48.0% | ||
| Q2 24 | -182.2% | -5.5% | ||
| Q1 24 | -138.9% | — |
资本支出强度
LAB
LPRO
| Q4 25 | — | 0.3% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 8.7% | 0.0% | ||
| Q1 25 | 12.4% | 0.2% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | 10.2% | 0.5% | ||
| Q2 24 | 8.6% | 0.2% | ||
| Q1 24 | 1.7% | 0.0% |
现金转化率
LAB
LPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | -6.22× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 7.92× | ||
| Q2 24 | — | -0.48× | ||
| Q1 24 | — | 2.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LPRO
暂无分部数据